Shan Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Photodynamic Therapy

Top Venues

Science advances

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Liu, Fenghua Chen, Shan Li, Tong Yang, ShuZhen Chen, Yang Zhou, Zejian Lin, Guandi Zeng, Pengju Feng, Hong-Bing Shu, Qian Zhou, Ke Ding, Liang Chen
Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8 + T cells in cis and in trans. Science advances 10 (34) (2024)
Lu Liu, Fenghua Chen, Shan Li, Tong Yang, ShuZhen Chen, Yang Zhou, Zejian Lin, Guandi Zeng, Pengju Feng, Hong-Bing Shu, Qian Zhou, Ke Ding, Liang Chen
Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8 + T cells in cis and in trans. Science advances 10 (34) (2024)
Lu Liu, Fenghua Chen, Shan Li, Tong Yang, ShuZhen Chen, Yang Zhou, Zejian Lin, Guandi Zeng, Pengju Feng, Hong-Bing Shu, Qian Zhou, Ke Ding, Liang Chen
Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8 + T cells in cis and in trans. Science advances 10 (34) (2024)
Shan Li, Hongfei Si, Xiaojuan Song, Chong Lei, Xiaoqiang He, Jie Wang, Yiling Liu, Yang Zhou, Jian-Guo Song, Lijie Peng, Xia Tang, Shingpan Chan, Xiaomei Ren, Zhengchao Tu, Zhengqiu Li, Zhen Wang, Zhang Zhang, Ke Ding
Discovery of Hexahydrofuro[3,2- b ]furans as New Kinase-Selective and Orally Bioavailable JAK3 Inhibitors for the Treatment of Leukemia Harboring a JAK3 Activating Mutant. Journal of medicinal chemistry 65 (15) (2022)
Shan Li, Tao Zhang, Su-Jie Zhu, Chong Lei, Mengzhen Lai, Lijie Peng, Linjiang Tong, Zilu Pang, Xiaoyun Lu, Jian Ding, Xiaomei Ren, Cai-Hong Yun, Hua Xie, Ke Ding
Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFR T790M/C797S Mutants. ACS medicinal chemistry letters 13 (2) (2022)